Structured evidence table for Sulforaphane Blood Glucose Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Sulforaphane Blood Glucose Randomized Trial | The positive symptoms manifest as hallucinations, delusions, and disorganized speech or behavior, while the negative symptoms consist of cognitive impairment with reduced motivation and expressiveness factors that affect memory and mental processing [,]. | 1 | Kassar Omar (2025) | Efficacy and safety of sulforaphane in schizophrenia: a systematic review and meta-analysis of randomized controlled trials |
| Sulforaphane Blood Glucose Randomized Trial | Patients with schizophrenia have a mortality rate of 2-3-fold compared to healthy people, with a reduced expected life of 10–20 years []. | 1 | Kassar Omar (2025) | Efficacy and safety of sulforaphane in schizophrenia: a systematic review and meta-analysis of randomized controlled trials |
| Sulforaphane Blood Glucose Randomized Trial | The main goal of antipsychotics is restoring the patient’s normal daily functioning, followed by maintenance doses of therapy to prevent the risk of hospitalization and improve quality of life []. | 1 | Kassar Omar (2025) | Efficacy and safety of sulforaphane in schizophrenia: a systematic review and meta-analysis of randomized controlled trials |
| Sulforaphane Blood Glucose Randomized Trial | 1 2 3 4 5 6 7 Schizophrenia is one of the most prevalent long-term disabling psychiatric disorders, affecting around 0.7% to 1% of the general population []. | 1 | Kassar Omar (2025) | Efficacy and safety of sulforaphane in schizophrenia: a systematic review and meta-analysis of randomized controlled trials |
| Sulforaphane Blood Glucose Randomized Trial | Substantial evidence has supported the beneficial role of healthy dietary factors in preventing the occurrence and development of CMDs and atherosclerosis in the aging population [,,,]. | 2 | Wu Qi (2026) | Effects of a cardiometabolic risk–reducing dietary pattern health education intervention on cardiometabolic disease risk in community-dwelling older adults in China: a cluster-randomized clinical trial |
| Sulforaphane Blood Glucose Randomized Trial | Therefore, we performed a 12-month cluster-randomized controlled intervention trial to evaluate the effects of the RCMDR dietary pattern on clustered cardiometabolic risk, common carotid artery (CCA) atherosclerosis parameters, CMD risk factors (blood lipids, blood glucose, insulin sensitivity, homocysteine (Hcy), blood pressure) and body composition in community-dwelling older adults. | 2 | Wu Qi (2026) | Effects of a cardiometabolic risk–reducing dietary pattern health education intervention on cardiometabolic disease risk in community-dwelling older adults in China: a cluster-randomized clinical trial |
| Sulforaphane Blood Glucose Randomized Trial | 13 The primary outcome was the clustered cardiometabolic disease risk score (CMRS), calculated in the same way as in previously published study using waist circumference (WC), systolic blood pressure (SBP), diastolic blood pressure (DBP), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), and fasting glucose (FBG)[]. | 2 | Wu Qi (2026) | Effects of a cardiometabolic risk–reducing dietary pattern health education intervention on cardiometabolic disease risk in community-dwelling older adults in China: a cluster-randomized clinical trial |
| Sulforaphane Blood Glucose Randomized Trial | [1] [2] [3] 4 5 3 6 [7] [8] [9] [10] Cardiometabolic diseases (CMDs), including a series of interrelated diseases, such as hypertension, diabetes, dyslipidemia, coronary heart disease and stroke, are the leading causes of death and disability worldwide and also pose a serious threat to the health of Chinese residents [,,]. | 2 | Wu Qi (2026) | Effects of a cardiometabolic risk–reducing dietary pattern health education intervention on cardiometabolic disease risk in community-dwelling older adults in China: a cluster-randomized clinical trial |
Source documents